Prognosis

BioNTech Says State Aid Can Boost Vaccine Capacity: Spiegel

Company asked if it can produce 3 billion doses in 2022
Manufacturer is looking to add partners to European network

BioNTech Says Making More Covid-19 Doses Depends on Many Factors

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Richard Weiss

February 6, 2021 at 1:55 PM UTC

Updated on

February 7, 2021 at 4:43 PM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Funding from Germany or the European Union could help BioNTech SE increase production capacity for its Covid-19 vaccine, the company’s finance chief said in an interview.